NHI beats Q2 expectations, raises full-year NAREIT FFO guidance to $4.50-$4.54

NATIONAL HEALTH INVESTORS INC

2024-Q2 EPS reported $1.52 revenue$166,482,000

Net income per diluted share $0.81 vs $0.92 YoY; NAREIT FFO per share $1.18 vs $1.05 YoY.
Normalized FFO per share $1.18 vs $1.06; Normalized FAD $51.8M vs $44.6M YoY.
2024 NAREIT FFO guidance raised to $4.50-$4.54 from $4.36-$4.41; Normalized FFO to $4.52-$4.56.
Closed $56.6M YTD investments at 8.4% avg yield; signed LOIs for $155.4M at ~8.4% yield.
SHOP occupancy rose to 88.2% in July 2024 from 75.6% in July 2023; net debt/EBITDA within target 4-5x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.